Melphalan on day -1 versus day -2 in patients with plasma cell disorders undergoing autologous stem cell transplant.
J Oncol Pharm Pract
; 29(6): 1398-1403, 2023 Sep.
Article
in En
| MEDLINE
| ID: mdl-36245321
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Hematopoietic Stem Cell Transplantation
/
Multiple Myeloma
Limits:
Humans
Language:
En
Journal:
J Oncol Pharm Pract
Journal subject:
FARMACIA
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom